Moncef Slaoui is the former chairman of research and development at GlaxoSmithKline and sits on the company's corporate executive team and board of directors. He also has overall responsibility for GSK's vaccines and oncology businesses and new product launches. In his early work as a scientist, he helped build the vaccines pipeline and played an important role in the discovery of a vaccine for childhood malaria. As chairman of R&D, he has spearheaded a profound overhaul of GSK's pharmaceutical R&D resulting in a substantial improvement in productivity.

On May 15, 2020, President Donald Trump announced that Slaoui would manage the U.S. government's development of a vaccine used to treat coronavirus disease in Operation Warp Speed.

Research scientist, Vaccines, Pharmaceutical, Human Resources, Scientists, Medicine, Health, COVID-19 Epidemics & Pandemics, Muslim,